<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7866062</article-id><article-id pub-id-type="pmid">33513835</article-id><article-id pub-id-type="doi">10.3390/molecules26030654</article-id><article-id pub-id-type="publisher-id">molecules-26-00654</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of Dimer of Epicatechin from an Endophytic Fungus <italic>Curvularia australiensis</italic> FC2AP on Acute Toxicity Levels, Anti-Inflammatory and Anti-Cervical Cancer Activity in Animal Models</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mani</surname><given-names>Vellingiri Manon</given-names></name><xref ref-type="aff" rid="af1-molecules-26-00654">1</xref><xref ref-type="aff" rid="af2-molecules-26-00654">2</xref><xref ref-type="author-notes" rid="fn1-molecules-26-00654">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Soundari</surname><given-names>Arockiam Jeyasundar Parimala Gnana</given-names></name><xref ref-type="aff" rid="af2-molecules-26-00654">2</xref><xref ref-type="aff" rid="af3-molecules-26-00654">3</xref><xref ref-type="author-notes" rid="fn1-molecules-26-00654">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6938-1495</contrib-id><name><surname>Balasubramanian</surname><given-names>Balamuralikrishnan</given-names></name><xref ref-type="aff" rid="af4-molecules-26-00654">4</xref><xref rid="c1-molecules-26-00654" ref-type="corresp">*</xref><xref ref-type="author-notes" rid="fn1-molecules-26-00654">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7684-9719</contrib-id><name><surname>Park</surname><given-names>Sungkwon</given-names></name><xref ref-type="aff" rid="af4-molecules-26-00654">4</xref></contrib><contrib contrib-type="author"><name><surname>Issara</surname><given-names>Utthapon</given-names></name><xref ref-type="aff" rid="af5-molecules-26-00654">5</xref></contrib><contrib contrib-type="author"><name><surname>Preethi</surname><given-names>Kathirvel</given-names></name><xref ref-type="aff" rid="af2-molecules-26-00654">2</xref><xref rid="c1-molecules-26-00654" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Wen-Chao</given-names></name><xref ref-type="aff" rid="af6-molecules-26-00654">6</xref><xref rid="c1-molecules-26-00654" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Kubina</surname><given-names>Robert</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Kaba&#x00142;a-Dzik</surname><given-names>Agata</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-26-00654"><label>1</label>Department of Biotechnology, Rathnavel Subramaniam College of Arts and Science, Coimbatore, Tamil Nadu 641402, India; <email>manonmanisathee12@gmail.com</email></aff><aff id="af2-molecules-26-00654"><label>2</label>Department of Microbial Biotechnology, Bharathiar University, Coimbatore-46, Tamil Nadu 641046, India; <email>apgs_1987@yahoo.co.in</email></aff><aff id="af3-molecules-26-00654"><label>3</label>Department of Environmental Science &#x00026; Engineering, College of Natural Resources &#x00026; Environment, Northwest A &#x00026; F University, Xianyang 712100, China</aff><aff id="af4-molecules-26-00654"><label>4</label>Department of Food Science and Biotechnology, College of Life Science, Sejong University, Seoul 05006, Korea; <email>sungkwonpark@sejong.ac.kr</email></aff><aff id="af5-molecules-26-00654"><label>5</label>Division of Food Science and Technology Management, Faculty of Science and Technology, Rajamangala University of Technology Thanyaburi, Pathum Thani 12110, Thailand; <email>utthapon_i@rmutt.ac.th</email></aff><aff id="af6-molecules-26-00654"><label>6</label>Department of Animal Science, College of Agriculture, Guangdong Ocean University, Zhanjiang 524088, China</aff><author-notes><corresp id="c1-molecules-26-00654"><label>*</label>Correspondence: <email>bala.m.k@sejong.ac.kr</email> (B.B.); <email>preethi@buc.edu.in</email> (K.P.); <email>liuwc@gdou.edu.cn</email> (W.-C.L.)</corresp><fn id="fn1-molecules-26-00654"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>27</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2021</year></pub-date><volume>26</volume><issue>3</issue><elocation-id>654</elocation-id><history><date date-type="received"><day>20</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>22</day><month>1</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Cervical cancer, as the most frequent cancer in women globally and accounts almost 14% in India. It can be prevented or treated with vaccines, radiation, chemotherapy, and brachytherapy. The chemotherapeutic agents cause adverse post effects by the destruction of the neighboring normal cells or altering the properties of the cells. In order to reduce the severity of the side effects caused by the chemically synthesized therapeutic agents, the current research developed an anti-cancer agent dimer of epicatechin (DoE), a natural bioactive secondary metabolite (BSM) mediated from an endophytic fungus <italic>Curvularia australiensis</italic> FC2AP. The investigation has initiated with the evaluation of inhibiting the angiogenesis which is a main activity in metastasis, and it was assessed through Hen&#x02019;s Egg Test on Chorio Allantoic Membrane (HET-CAM) test; the BSM inhibited the growth of blood vessels in the developing chick embryo. Further the DoE was evaluated for its acute toxicity levels in albino mice, whereas the survival dose was found to be 1250 mg/kg and the lethal dose was 1500 mg/kg body weight of albino mice; hematological, biochemical, and histopathological analyses were assessed. The anti-inflammatory responses of the DoE were evaluated in carrageenan induced Wistar rats and the reduction of inflammation occurred in a dose-dependent manner. By fixing the effective dose for anti-inflammation analysis, the DoE was taken for the anti-cervical cancer analysis in benzo (a) pyrene induced female Sprague-Dawley rats for 60 days trial. After the stipulated days, the rats were taken for hematological antioxidants, lipid peroxidation (LPO), member bound enzymes, cervical histopathological and carcinogenic markers analyses. The results specified that the DoE has the capability of reducing the tumor in an efficient way. This is the first report of flavonoid-DoE production from an endophytic fungus <italic>C. australiensis</italic> has the anticancer potentiality and it can be stated as anti-cancer drug.</p></abstract><kwd-group><kwd>acute toxicity</kwd><kwd>albino mice</kwd><kwd>anti-cancer</kwd><kwd>anti-inflammatory</kwd><kwd>cervical cancer</kwd><kwd>dimer of epicatechin</kwd><kwd>metabolites</kwd><kwd>Sprague-Dawley rats</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-26-00654"><title>1. Introduction</title><p>Cervical cancer is the most malignant cancer in the women ranking second globally and it affects the women aged from 35 to 60 years [<xref rid="B1-molecules-26-00654" ref-type="bibr">1</xref>]. Majorly it was caused by human papilloma virus (HPV) infections such as high risk and low risk HPV infections. Apart from HPV infections still there are many other factors, such as history of genital warts, AIDS patients, tobacco smoking, and multiple sexual partners, which play their role in inducing the cervical cancer and lesions [<xref rid="B2-molecules-26-00654" ref-type="bibr">2</xref>,<xref rid="B3-molecules-26-00654" ref-type="bibr">3</xref>]. The treatment for cervical cancer begins with chemotherapy, surgery, and radiotherapy; these therapies remains to be the major strategies in treating not only cervical cancer but also other types of cancer. The chemotherapy has certain extent in saving many lives but still this therapy produces some immunological ill effects in the patients [<xref rid="B4-molecules-26-00654" ref-type="bibr">4</xref>]. The chemotherapy includes the chemical or artificial medicinal agents which alters and damages the DNA in the tumor cells which reduces the ill-effect of cancer. These side effects could be reduced or prevented by the implementation of natural cancer therapeutic agents. The natural bioactive agents or products can be extracted from plants, algal, and microbial sources. The Indian traditional medicinal system has several medicines which can treat various types of diseases and disorders using medicinal plants and trees. However, it is not possible to cut down or damage the plants/trees for retrieving the medicines, as for treating a single patient it is necessary to take at least 1 kg of the plant sources. So the current research has aimed to isolate an endophytic fungi residing in the medicinal tree that could possess the metabolic nature of the host tree and aids in the production of the expected bioactive cancer therapeutic agent from a microbe which could be produced maximum quantity in a minimum culture area.</p><p>The endophytic fungi contain a broad classification of bioactive secondary metabolites (BSMs) with distinctive nature including alkaloids, flavonoids, phenols/polyphenols, benzopyranones, quinones, chinones, terpenoids, steroids, tetralones, and xanthones [<xref rid="B5-molecules-26-00654" ref-type="bibr">5</xref>]. Most of the BSMs are effectively used in the medicinal field as cancer therapeutic agents which prevented/treated successfully. Wu et al. [<xref rid="B6-molecules-26-00654" ref-type="bibr">6</xref>] explored that the anti-cancer activity exhibited by the potential endophytic fungal strains in breast cancer cell lines. The strains of <italic>Aspergillus</italic> produced the anti-tumor compounds and explored its therapeutic properties in inhibiting the growth of MCF-7 cells [<xref rid="B7-molecules-26-00654" ref-type="bibr">7</xref>,<xref rid="B8-molecules-26-00654" ref-type="bibr">8</xref>]. Majoumouo et al. [<xref rid="B9-molecules-26-00654" ref-type="bibr">9</xref>] has reported that the potential anti-cervical cancer properties in metabolites extracted from the endophytic fungal strains such as <italic>Fusarium</italic>, <italic>Phoma</italic>, and <italic>Colletotrichum</italic> species. He et al. [<xref rid="B4-molecules-26-00654" ref-type="bibr">4</xref>] reported that the anti-cancer activities of BSMs from the endophytic fungi and the BSMs explicated the anti-cervical cancer activity efficiently in animal models. On comparing to other therapeutic metabolites epicatechins and its derivatives were found to exhibit the highest cancer therapeutic properties especially in treating and preventing the cervical cancer [<xref rid="B10-molecules-26-00654" ref-type="bibr">10</xref>]. These epicatechins and its derivatives have been reported to exhibit the anti-tumor activities by the inactivation of tumor metabolic pathways in various kinds of cancer. The epicatechins derivatives inhibits the activation of STAT3 pathway which has a significant role in the formation of tumor, and this was reported in nasopharyngeal carcinoma [<xref rid="B11-molecules-26-00654" ref-type="bibr">11</xref>]. Few researches supports the anti-cancer activities explicated by the epicatechin derivatives in the prevention and decrease of tumor formation, progression, and metastasis stages [<xref rid="B12-molecules-26-00654" ref-type="bibr">12</xref>,<xref rid="B13-molecules-26-00654" ref-type="bibr">13</xref>,<xref rid="B14-molecules-26-00654" ref-type="bibr">14</xref>,<xref rid="B15-molecules-26-00654" ref-type="bibr">15</xref>]. These epicatechins are also helpful in the prevention and curing of neurodegenerative diseases [<xref rid="B16-molecules-26-00654" ref-type="bibr">16</xref>]. Elbaz et al. [<xref rid="B17-molecules-26-00654" ref-type="bibr">17</xref>] reported the anti-pancreatic cancer activity exhibited by the epicatechins where the metabolites stimulated the mitochondrial activity upon radiation exposure. Moreover, the epicatechins are a good anti-proliferative agents in breast cancer cells when there are bio catalytically oligomerized [<xref rid="B18-molecules-26-00654" ref-type="bibr">18</xref>].These epicatechins family are highly present in tea plant but this epicatechin derivatives was remarkably present in an endophytic fungus <italic>Curvularia australiensis</italic>. The presence of epicatechins in <italic>C. australiensis</italic> was from the metabolic process mimicked from the host tree <italic>Aegle marmelos</italic> [<xref rid="B19-molecules-26-00654" ref-type="bibr">19</xref>]. The <italic>Curvularia</italic> species are found to contain more medically important metabolites and few research reports were found to explicate the results on potential metabolites. The <italic>Curvularia</italic> sp. was isolated from <italic>Murraya koengii</italic> was found to exhibit the inhibition of <italic>Phytophthora capsica</italic> zoospores [<xref rid="B20-molecules-26-00654" ref-type="bibr">20</xref>]. Khiralla [<xref rid="B21-molecules-26-00654" ref-type="bibr">21</xref>] reported that the cytotoxicity effects of metabolites produced by an endophytic fungus <italic>C. papendroffi</italic> and its effect on cancer cells. There are only few researches on the metabolites produced by the <italic>C. australiensis</italic> in medicinal fields. The goal of this current investigation was to evaluate the effects of dimer of epicatechin (DoE) on anti-angiogenesis, anti-inflammation, and anti-cervical cancer properties through in vitro and in vivo animal studies.</p></sec><sec sec-type="methods" id="sec2-molecules-26-00654"><title>2. Methodology</title><sec id="sec2dot1-molecules-26-00654"><title>2.1. Curvularia australiensis Strain and Source</title><p>This investigation has focused to characterize the anti-cancer potentiality of the DoE produced by an endophyte <italic>C. australiensis</italic> FC2AP. This strain was isolated from a medicinal tree <italic>Aegle marmelos</italic> grown around the foothills of Vellingiri hills, Western Ghats regions (Nilgiris cluster), Coimbatore, Tamil Nadu, India. The strain FC2AP (NCBI accession number: KR363626) was isolated from the leaf sample of the <italic>A. marmelos</italic> tree; the strain was found to dwell and produce maximum metabolites in Sabouraud&#x02019;s Dextrose Broth medium [<xref rid="B22-molecules-26-00654" ref-type="bibr">22</xref>]. The preliminary research of this study such as isolation, identification, and characteristics of the isolated endophytic fungus <italic>C. australeinsis</italic> FC2AP was stated in the earlier investigation of Mani et al. [<xref rid="B22-molecules-26-00654" ref-type="bibr">22</xref>]. The DoE was purified through HPLC (High Performance Liquid Chromatography) technique from crude pigmented metabolites extract-CPME (biomass-intracellular extract) produced by <italic>C. australiensis</italic> in Sabouraud&#x02019;s Dextrose Broth medium; this medium was optimized using experimental design- RSM executed through Stat-Ease software. There were six peaks (MM1 to MM6) when CPME was eluted at 554 nm and those eluted fractions were subjected to antimicrobial and antioxidant analyses where the highest peak (MM4) exhibited the maximum activity at minimum concentration. The MM4 was put through for chemical characterization of the structure with the aid of UV-Vis spectrum, FT-IR, 1H, and 13C NMR, and HRLC-MS/MS analyses. With these data, the compound MM4 was found to be DoE with the molecular mass of 573.1991 (C<sub>30</sub>H<sub>22</sub>O<sub>12</sub>). The elucidated DoE was investigated for anti-cervical cancer properties on cancer cell lines HeLa and the DoE explicated its anti-cancer potentiality where the cell viability in HeLa cells was found to be 48.38% at 100 &#x000b5;g/mL concentration (unpublished data).</p></sec><sec id="sec2dot2-molecules-26-00654"><title>2.2. In Vitro Study: Anti-Angiogenic Analysis</title><p>This analysis was executed by Hen&#x02019;s Egg Test on Chorio Allantoic Membrane (HET- CAM), assessed to observe the inflammation/inhibition of tissue reactions by the BSM- DoE on the growing tissues and blood vessels [<xref rid="B23-molecules-26-00654" ref-type="bibr">23</xref>]. The shell and capsular membrane of 9th day embryonated egg was carefully removed, and the DoE of 200 &#x000b5;L concentration was dispensed on small discs in triplicates and those discs were carefully inserted into the Chorio Allantoic Membrane. The number of blood vessels were counted at initial and after the incubation period of 2 and 18 h; this confirms the inhibition of angiogenic process. The positive control and negative control used in this evaluation were 0.1 N NaOH and 0.9% NaCl.</p></sec><sec id="sec2dot3-molecules-26-00654"><title>2.3. In Vivo Studies: Animal Models</title><p>The effectiveness of the DoE as a drug constituent has been tested out in the living biological system, the mice and rat models were prominent for checking the effect of compound DoE in in vivo analysis. The acceptance of new drug in the medicinal field is only after the drug has to be approved as non-toxic compound in the animal system. Hence the animal studies have been carried out using mice and rat as model systems. The animals used in this study were purchased from M/s. Venkateshwara Animal Breeders Pvt. Ltd., Bangalore, India. The animals were randomly selected and weighed to make certain of observance with the age invocated. The animals were accommodated in metabolic cages (size: 55(L) &#x000d7; 32.7(B) &#x000d7; 19(H) cm), with sawdust scraps, and each cage was accommodated with a maximum of 6 animals (same sex should be in a single cage).</p><p>All animals were kept in observation and acclimatization for a period of 20 date from the arrival date and the onset of treatment. The animals were examined by a veterinary physician to certify the fulfillment of health precondition for initiation of the research study. The rats were individually identified by the tattoos on the various parts of the body [Head (H), body (B), tail (T), head body (HB), body tail (BT), and no mark (NM)]. The marking of the animals was performed when the animals were distributed among the study groups. All animal procedures were performed in accordance with Institutional Animal Ethic Committee guidelines, after getting the approval from the Committee for the Purpose of Control and Supervision of Experiment on Animals at KMCH college of Pharmacy, Coimbatore, Tamil Nadu, India (IAEC No. KMCRET/Ph.D/05/2014-15).</p><sec id="sec2dot3dot1-molecules-26-00654"><title>2.3.1. Acute Toxicity Study</title><sec><title>Animal and Experimental Design</title><p>Acute oral toxicity was performed as per Organization for Economic Co-operation for Development guideline 423 methods. A total of sixty albino mice (8&#x02013;10 weeks old with, initial average weight of 25&#x02013;30 g; mixed gender) are fasted 6 h prior to dosing (food was withheld for 3 h but not water). Following the period of fasting, animals were weighed, and test substance DoE was administered orally in various concentration such as 2 g, 1.75 g, 1.5 g, 1.25 g, 1 g, 0.75 g, 0.5 g, 0.35 g, 0.25 g, and 0.1 g using specially designed mice oral needle. A total number of six animals were used for each dosage in each group and after the administration, food was withheld for 2 h. Animals were observed individually at least once during the first 1 h, periodically during the first 24 h, with special attention given during the first 4 h, and daily thereafter for 3 days, and for a total of 7 days. Animals were observed for their alertness, grooming, touch, torch and pain responses, tremors, convulsion, righting, pinna and corneal reflexes, gripping strength, pupils, urination, salivation, change in skin color, lacrimation and also for hyperactivity before and after administration of test samples. From these, the effective dosage and lethal dosage has been fixed.</p></sec><sec><title>Samples and Analysis</title><p>The animals were anaesthetized following the treatment period of 7 days, using ketamine hydrochloride and the blood was fetched from the animal&#x02019;s retro-orbital sinus (three animals from each group). The collected blood was dispensed into the respective centrifuge tube containing an anti-coagulant-EDTA and further used hematological experiments. The hematological parameters like hemoglobin, Red Blood Cells (RBC), White Blood cells (WBC), Mean Corpuscular Volume (MCV), Packed Cell Volume (PCV), Mean Platelet Volume (MPV), differential cell count, Mean Corpuscular Hemoglobin Concentration (MCHC), and Mean Corpuscular Hemoglobin (MCH) count were determined [<xref rid="B24-molecules-26-00654" ref-type="bibr">24</xref>,<xref rid="B25-molecules-26-00654" ref-type="bibr">25</xref>,<xref rid="B26-molecules-26-00654" ref-type="bibr">26</xref>,<xref rid="B27-molecules-26-00654" ref-type="bibr">27</xref>]. The determination of biochemicals functioning, the separated serum from the collected blood sample was used and various biochemical parameters such as alkaline phosphatase (ALP), aspartate transaminase (AST), Alanine transaminase (ALT) [<xref rid="B28-molecules-26-00654" ref-type="bibr">28</xref>,<xref rid="B29-molecules-26-00654" ref-type="bibr">29</xref>], bilirubin, and total protein (TP) [<xref rid="B30-molecules-26-00654" ref-type="bibr">30</xref>] were analyzed. Protein measurement was done using Folin&#x02019;s phenol reagent.</p><p>Histopathological analysis reveals the pathological implications on tissues, and this was observed through microscopy. The tissues from various organs of healthy and dead animals were collected wither from biopsy or necropsy. Thin pieces of 3 to 5 mm thickness were sectioned, and the tissue(s) was kept in fixative (10% Formalin) for 24&#x02013;48 h at room temperature. The section was deparaffinized using xylol for 5&#x02013;10 min and excess xylol was removed by absolute alcohol. Then the section was cleaned and stained with hematoxylin for 3&#x02013;4 min. The section was then counter stained with 0.5% eosin (15&#x02013;30 s), excess stain was removed. The section was blotted, dehydrated in alcohol and cleared with xylol (15&#x02013;30 s). It was then mounted on a Canada balsam or DPX Mountant. Further, the slide was kept dry and without air bubbles for future studies.</p></sec></sec><sec id="sec2dot3dot2-molecules-26-00654"><title>2.3.2. Anti-Inflammatory Study</title><p>Female Wister albino rats weighed around 150 to 175 g were used for this study. The animals were segregated into five groups with six animals in each. The dosages received by the experimental groups were Group-I (Control-Without any sample and/ or negative control), Group-II (Negative control&#x02014;0.1 mL of 1% carrageenan alone), Group-III (Standard&#x02014;Indomethacin (20 mg/kg) + 0.1 mL of 1% carrageenan), Group-IV (DoE (125 mg/kg) + (0.1 mL of 1% carrageenan), Group V (DoE (300 mg/kg) + (0.1 mL of 1% carrageenan]. The carrageenan administered as 1% <italic>w</italic>/<italic>v</italic> solution to rats via subcutaneous injection in the left paw-sub plantar region. The paw was stained with temporary ink at the intensity of sideways ankle bone (malleolus) and drenched in mercury up to the mark. The paw volume was measured using Digital Plethysmometer at 0, 1, 2, 3, 4, 5, and 6 h after carrageenan injection. The differentiation between initial and succeeding reading provides the approximate edema volume.</p></sec><sec id="sec2dot3dot3-molecules-26-00654"><title>2.3.3. Anti-Cancer Study</title><p>For this study, the animals were segregated into seven groups with six animals/group female Sprague Dawley (SD). The experimental groups were assigned as: Group I: control (without any test samples or negative sample); Group II: BaP only (negative control); Group III: BaP + cisplastin (10 mg/kg of SD rat&#x02019;s body weight); Group IV: DoE (100 mg/kg) + BaP (10 mg/kg); Group V: DoE (150 mg/kg) + BaP (10 mg/kg); Group VI: DoE (200 mg/kg) + BaP (10 mg/kg); Group VII: DoE (250 mg/kg) + BaP (10 mg/kg). The cervical cancer was induced in SD rats using BaP [Benzo (a) pyrene] dissolved in corn oil. The SD rats are the best animal model for studying the anti-cancer evaluation especially for the investigation of reproductive tract cancers. The BaP was finely dissolved in 0.2% of corn oil and administered to SD rats orally and similarly the test samples were put into SD rats orally using specially designed needle; but the cisplastin alone was administered intravenously. The BaP was given to SD rats at an interval of 4 days for about 8 weeks; cisplastin was injected twice a week to Group II animals for a period of 8 weeks and the DoE samples were administered to experimental grouped animals at an interval of four days for a period of 8 weeks. After the stipulated weeks, two SD rats were randomly selected from each group, sacrificed and analyzed for histopathological studies only as described in previously. The hematological and biochemical parameters for each tested group were analyzed from the blood samples withdrawn from three animals selected randomly in each group (<italic>n</italic> = 3).</p><p>Further the blood and tissue samples were analyzed for serum tumor markers carcinoembryonic antigen (CEA), gamma-glutamyltransferase (GGT) according to the method of He et al. [<xref rid="B31-molecules-26-00654" ref-type="bibr">31</xref>]. The antioxidants and membrane bound enzymes in treated animal samples such as superoxide dismutase (SOD) [<xref rid="B32-molecules-26-00654" ref-type="bibr">32</xref>], catalase (CAT), glutathione peroxidase (GPx), total reduced GSH, lipid peroxidation (LPO), and Na<sup>+</sup>K<sup>+</sup> adenosine triphosphatase [ATPase], Ca<sup>+</sup> ATPase and Mg+ ATPase were estimated, respectively [<xref rid="B33-molecules-26-00654" ref-type="bibr">33</xref>].</p></sec></sec><sec id="sec2dot4-molecules-26-00654"><title>2.4. Statistical Analysis</title><p>The experiments conducted in this investigation were analyzed using statistical tools such as MS Excel and Origin software (OriginPro 2016, Origin Lab Corporation, Northampton, MA, USA). All the values represented in the graphs were mean with standard deviation. The ANOVA significance were depicted in different letters on the respective groups and experiments; the statistical significance was determined using Tukey HSD (honestly significant difference) test.</p></sec></sec><sec sec-type="results" id="sec3-molecules-26-00654"><title>3. Results</title><sec id="sec3dot1-molecules-26-00654"><title>3.1. Anti-Angiogenic Study by HET-CAM Analysis</title><p>The CAM assay is a perceptive, easily feasible, and economy in vivo check for enquiries of the anti-angiogenic promise of individual compounds. The compound DoE exhibited a promising anti-angiogenesis by the inhibition of angiogenesis at an interval of 2 h and 18 h and the inhibition percentage was 72.08% and 91.62, respectively (<xref rid="molecules-26-00654-t001" ref-type="table">Table 1</xref> and <xref ref-type="fig" rid="molecules-26-00654-f001">Figure 1</xref>). The solvent acetone explored its potentiality by inhibiting 18.8% and 27.27% for 2 h and 18 h, respectively. This evinced that the DoE has the good anti-angiogenic potentiality which could be explored as anticancer agents.</p></sec><sec id="sec3dot2-molecules-26-00654"><title>3.2. Animal Studies</title><sec id="sec3dot2dot1-molecules-26-00654"><title>3.2.1. Acute Toxicity Analysis in Albino Mice</title><p>Acute toxicity is the adverse change(s) which occurs instantly or during a short time within 24 h of administration following a single or short period of exposure to the metabolite. The adverse effect may be any type of effect resulting in functional impairment and/or biochemical lesions which affects the normal activity of the whole organism or specifically disabling a single/multiple organ(s). For this study, the various dosage levels (2 g (Gp II), 1.75 g (Gp III), 1.5 g (Gp IV), 1.25 g (Gp V), 1 g (Gp VI), 0.75 g (Gp VII), 0.5 g (Gp VIII), 0.35 g (Gp IX), 0.25 g (Gp X), and 0.1 g (Gp XI) per Kg of mice, based on the OECD 423 guidelines) were fixed to determine the toxicity of the purified compound DoE in mice models (<xref ref-type="app" rid="app1-molecules-26-00654">Supplementary Table S1a&#x02013;j</xref>) and the control group animals were fixed in group I. Through this analysis the effective dosage for the survival of the animal was 1.25 g/kg (Gp V) and the lethal dosage was 1.5 g/kg (Gp IV). Above 1.5 g/kg of the DoE produced hyper sensitivity, righting reflex, tremors and convulsions leading to the death of the animal.</p><p>The hematological parameters were evaluated for the survival and lethal dosage grouped animals compared with control group (<xref ref-type="fig" rid="molecules-26-00654-f002">Figure 2</xref>A&#x02013;D). The RBC count was similar to the control group whereas the count was low in lethal group. The WBC count was highest in lethal group than control group, this is because the lethality has been identified by the immune system and thereby the cells arrives for defensive mechanism in order to eliminate the excessive toxicity out the body. The granulocytes (neutrophils, eosinophils and basophils) and agranulocytes (lymphocytes and monocytes) count of the blood sample was similar in both survival and control groups but there was a slight variation in the lethal group and this indicated the severity of overdose to the body weight. The hemoglobin, MCH and MCHC count were observed to be decreased in the lethal grouped animals when compared to survival and control grouped animals. The MCV and MPV were found to be similar in both control and group V animals but the volume was higher in lethal group. The packed cell volume (PCV) was higher than in group V and control group animals. This conclude that the DoE dose above 1.25 g/kg affects the blood cells and the total corpuscular volume.</p><p>Similarly, the biochemical parameters were evaluated for the control, survival, and lethal group (Group I, V, and IV) and results were depicted in <xref rid="molecules-26-00654-t002" ref-type="table">Table 2</xref>. The biochemical such as AST, ALT, ALP, bilirubin, and total proteins were found to be rising significant in an order for survival and lethal group when compared to control group. This implicit that the compound DoE is an effective drug which does not alter the biochemical and hematological parameters in the limited dosage.</p><p>A study has also been performed to check out the reason for lethality and survival in the above said dosages (Group IV and V) along with the control (Group I) through the histopathology analysis of five important organs such as liver, lungs, heart, brain, and kidneys. All the organs except the lung tissue were observed to be in normal cellular/tissue morphology (<xref ref-type="fig" rid="molecules-26-00654-f003">Figure 3</xref>A&#x02013;E) whereas the tissues from lungs of animals administered with lethal dose exhibited interconnected alveoli and this might be the prime reason behind the lethality of the animals.</p></sec><sec id="sec3dot2dot2-molecules-26-00654"><title>3.2.2. Anti-Inflammatory Study</title><p>From the earlier evaluation, the DoE was confirmed to be a potent free radical scavenger, as it has the capacity to reduce the inflammatory response of inflammation/ induced paw edema and this was assessed through carrageenan induced anti-inflammatory Wistar rat models. The investigation results revealed that the DoE is an effective metabolite in reducing the inflammation induced by carrageenan (<xref ref-type="fig" rid="molecules-26-00654-f004">Figure 4</xref> and <xref ref-type="fig" rid="molecules-26-00654-f005">Figure 5</xref>). The animals developed the maximum inflammatory response at 3 h of induction and after 3 h, the inflammation started to reduce gradually. The percentage of inhibition was found to be 41.09% (300 mg/kg) which was found to be twice than the standard drug indomethacin (20.17%) used. This proved the DoE was an efficient anti-inflammatory drug.</p></sec><sec id="sec3dot2dot3-molecules-26-00654"><title>3.2.3. Anti-Cancer Study</title><p>The excessive production of reactive oxygen species (ROS) in the cervical tissues/cells might damage and/or induces the rapid proliferation of cells and leads to cervical neoplasia, lesions, and carcinoma. There may be several reasons for the onset of cervical cancer such as human papilloma virus (HPV) infections, unhealthy lifestyle, etc., but the oxidative stress with the increased redox potentials is one the major reason for the carcinoma. The cervical tissues under severe alteration in the redox oxidative stress leads to change in the gene expression that might induces the cellular proliferation in a rapid state. The cervical cancer can be easily reduced or treated with the several medicines including traditional and food diet. One such potent therapeutic/medicine is polyphenols from natural sources containing the anti-cancer properties and there are several researches explicated the therapeutic nature of the polyphenols against cervical cancer. In this study the inhibition of cervical carcinoma&#x02019;s malignant stage was effectively treated by the phenolic product-DoE.</p><p>The blood cells such as RBC, WBC, agranulocytes, and granulocytes count were found to be normal in control, cisplatin treated, and DoE treated group of animals (<xref ref-type="fig" rid="molecules-26-00654-f006">Figure 6</xref>A) and the experiments were found to significant. There was a lowest count of blood cells in the group IV but when there was a steady increase in the dosage of DoE, the blood cells also reached the normal range. The antioxidants in the serum such as SOD, CAT, GPx, and GSH was similar in Group I, III, and VII; this exhibited the standard drug cisplatin and DoE has the similar therapeutic index (<xref ref-type="fig" rid="molecules-26-00654-f006">Figure 6</xref>B). The dose of 250 mg DoE has a good potential in the reduction of elevated oxidative stress and redox potentials, which could further aids in the normal cell functioning and apoptosis. Similarly, the antioxidants in the cervical tissues also found to be normal range in control, cisplatin and DoE treated animals (<xref ref-type="fig" rid="molecules-26-00654-f006">Figure 6</xref>B). The ANOVA for the groups tested for antioxidants presence in the serum and tissues were accounted as significant (<italic>p</italic> &#x0003c; 0.05). The LPO was measured by the production of MDA as an important oxidant which damages the DNA; this MDA is formed as an end product of LPO when the ROS reacts with the PUFA. The LPO in serum and tissues was found to higher in group II whereas there was a significant decrease when animals treated with cisplatin and DoE in a dose-dependent manner (<xref ref-type="fig" rid="molecules-26-00654-f006">Figure 6</xref>C). The count of membrane bound enzymes for the control and treated grouped animals were exhibited in the <xref ref-type="fig" rid="molecules-26-00654-f006">Figure 6</xref>C and there was a similar range found in both DoE and cisplatin treated animals; the test was significant with the p value of less than 0.05. The carcinogenic marker for the CEA and GGT for the control and treated groups were given in <xref ref-type="fig" rid="molecules-26-00654-f006">Figure 6</xref>D. The histopathological analysis of the cervical tissues for control and treated grouped animals were depicted in <xref ref-type="fig" rid="molecules-26-00654-f007">Figure 7</xref>.</p></sec></sec></sec><sec sec-type="discussion" id="sec4-molecules-26-00654"><title>4. Discussion</title><p>Cervical cancer is one of the biggest threats in the world among women and it is the second most common cancer [<xref rid="B32-molecules-26-00654" ref-type="bibr">32</xref>,<xref rid="B34-molecules-26-00654" ref-type="bibr">34</xref>]. The highest causative reason is oxidative stress, and this has to be managed properly otherwise the excessive production of ROS in the cell alters the gene expression and transcriptional factors leading to highest rate of cell progression. This is mainly caused by the poor presence of antioxidants in the cell and increased rate of ROS in the aerobic cells [<xref rid="B35-molecules-26-00654" ref-type="bibr">35</xref>]. The ROS are mainly formed during the oxidative phosphorylation in the mitochondria where the molecular oxygen (O<sub>2</sub>) changes into singlet O<sub>2</sub> or H<sub>2</sub>O<sub>2</sub> and this is initiated by the several processes such as UV or radiation exposures, chemical and mechanical stresses, inflammatory reactions and repeated microbial infections [<xref rid="B36-molecules-26-00654" ref-type="bibr">36</xref>,<xref rid="B37-molecules-26-00654" ref-type="bibr">37</xref>]. The increased progression of ROS or oxidative stress in the cervical tissues further alters the properties of DNA and progresses as cervical neoplasia, cervical tumor, and cervical cancer. The reduction of ROS and prevention of ROS can be easily succeeded with the aid of polyphenols and flavonoids which are effective antioxidants. Currently, several research focused to extract the polyphenols and flavonoids from endophytic fungi and the metabolites were explored as anti-cancer metabolites in medicinal fields [<xref rid="B3-molecules-26-00654" ref-type="bibr">3</xref>,<xref rid="B35-molecules-26-00654" ref-type="bibr">35</xref>].</p><p>The current investigation has produced and purified a potential polyphenolic DoE from a prospective endophytic fungus <italic>C. australiensis</italic> FC2AP and the DoE belongs to the class of chemical family, flavonoids. The flavonoids have therapeutic metabolites or products exhibiting the antimicrobial, antioxidant, antiviral, antiparasitic, and anti-cancer properties. Angiogenesis in tumor or tumor cells is a malignant stage and this could be minimized or prevented by the implementation of polyphenols and flavonoids. The preliminary assessment of inhibiting the angiogenesis process was successfully carried out through HET-CAM analysis in chick&#x02019;s embryonated eggs and the DoE inhibited and slowed down the formation of blood vessels in the embryo. The tumor progression at various sites are initiated by the onset of the angiogenesis process&#x02014;one of the characteristic in cancer cells, and thus the cancer cells are carried over the blood stream further invading any organs/sites in the body; this stage is called metastasis. Angiogenesis in tumors/carcinoma is an essential or vital component in cancer growth and propagation, and an important target for investigations related to its therapeutic use. It is significant to consider that tumor vascularization not only supply nutrients to tumors/tumor invasive areas, but also controls the physiopathology, and consequently its growth, metastasis in tumor [<xref rid="B38-molecules-26-00654" ref-type="bibr">38</xref>]. Thus, inhibiting tumor angiogenesis may halt the tumor growth and decrease metastatic potential of tumors. Yildiz et al. [<xref rid="B39-molecules-26-00654" ref-type="bibr">39</xref>] reported the inhibition of angiogenic effects using few anticancer products such as imatinib, diltiazem and bevacizumab. Pyripyropene A and hypocrimins (A and B) isolated from <italic>Aspergillus niger</italic> and <italic>Hypocrea vinosa,</italic> respectively, have good anti-angiogenic properties [<xref rid="B40-molecules-26-00654" ref-type="bibr">40</xref>]; Similarly a synthetic analogue pinabulin was derived from <italic>Aspergillus</italic> sp. and fumagillin from <italic>A. fumigatus</italic> have been exhibiting the anti-angiogenic effects.</p><p>Further the metabolite DoE was subjected to in vivo studies (animal models) in a sequential manner starting with the dosage fixing through acute toxicity analysis. Usually, any drug of 2 g/kg body weight of the animal is a lethal dose and in this investigation the animals survived at the 75% of maximum dosage level. The highest survival rate of the animals in this toxicity analysis was due to the DoE which is a polyphenol compound explicating the antioxidant properties. The catechins and epicatechins contains the properties such as antioxidants, anti-angiogenic, anti-proliferative, proapoptotic, anti-metastatic, and cell cycle perturbation [<xref rid="B35-molecules-26-00654" ref-type="bibr">35</xref>,<xref rid="B41-molecules-26-00654" ref-type="bibr">41</xref>,<xref rid="B42-molecules-26-00654" ref-type="bibr">42</xref>,<xref rid="B43-molecules-26-00654" ref-type="bibr">43</xref>]. The hematological and biochemical parameters are the most sensitive parameters for the analysis of toxicity in the animals and human; moreover, the determination assess the pathophysiological conditions in the blood stream [<xref rid="B44-molecules-26-00654" ref-type="bibr">44</xref>,<xref rid="B45-molecules-26-00654" ref-type="bibr">45</xref>].</p><p>Inflammation is the major problem in the tumor progression because the long-term inflammation in a site of the body could eventually leads to the formation of cancer. Balkwill and Mantovani [<xref rid="B46-molecules-26-00654" ref-type="bibr">46</xref>] found out there was a correlation between the inflammation and cancer, and this condition is a predisposition of cancer. The inflammation may be due to prolonged infections by the microbial invasions and if the infection were untreated in the specific cervical tissues that could eventually leads to the neoplasia or cervical carcinoma. Moreover, the inflammation promotes the malignant tumor growth or progression in the surrounding tissues of the inflammation area and this inflammation is a chronic and unregulated process [<xref rid="B47-molecules-26-00654" ref-type="bibr">47</xref>]. The alteration in the gene expression in the inflammation surrounding cells/tissues is induced by the production of ROS or nitrogen species in the inflammation site. As a result of the alteration in the genetic factors, the inflammation plays a crucial role in initiation of tumor, malignancy and metastatic processes [<xref rid="B48-molecules-26-00654" ref-type="bibr">48</xref>]. Various factors like bradykinins, histamines, serotonine, prostaglandins, oxidative stress, and free radicals such as superoxide anion, NO, and hydroxyl radicals are responsible for inflammation [<xref rid="B49-molecules-26-00654" ref-type="bibr">49</xref>,<xref rid="B50-molecules-26-00654" ref-type="bibr">50</xref>]. In this investigation, 1/10th of the effective dose was taken for the anti- inflammatory analysis in carrageenan-induced Wistar rats. Carrageenan-induced paw edema is a widely used test to determine the anti-inflammatory activity [<xref rid="B51-molecules-26-00654" ref-type="bibr">51</xref>]. The DoE reduced the inflammation within few hours and this explicit the DoE has the capability in decreasing vascular permeability and cellular infiltration where the accumulation of leukocytes, proteins and fluids are minimized by the respective DoE dosage levels. The given DoE has the capacity in clearing out the debris and scavenges the ROS and/or free radicals in the injured or inflamed site which prevents the damages or alteration in the DNA of the cells [<xref rid="B52-molecules-26-00654" ref-type="bibr">52</xref>].</p><p>With the results of anti-inflammatory responses, the cervical carcinoma analysis was assessed in BaP induced cancer Sprague Dawley rats. The cancer markers, antioxidants in serum and tissues, LPO in serum and tissues were found to be normal in DoE treated animals and the count were similar to the control group animals. Moreover, the DoE treated grouped results exhibited good survival rate and the hematological parameters were approximate with the blood count of standard drug: cisplatin treated animals. The endophytic fungal metabolites are very efficient in treating various types of cancer and there were several researches found various types of anti-tumor metabolites [<xref rid="B53-molecules-26-00654" ref-type="bibr">53</xref>,<xref rid="B54-molecules-26-00654" ref-type="bibr">54</xref>]. He et al. [<xref rid="B4-molecules-26-00654" ref-type="bibr">4</xref>] identified that the anti-cancer therapeutic secondary metabolite from an endophytic fungus <italic>Gingko biloba</italic> and the metabolite exhibited effective activity against cervical cancer in mice. The metabolites such as catechins, epicatechins, epigallocatechin gallate, and epigallocatechin are efficient antioxidants, and these are highly present in the green tea [<xref rid="B55-molecules-26-00654" ref-type="bibr">55</xref>]. Shibuya et al. [<xref rid="B56-molecules-26-00654" ref-type="bibr">56</xref>] reported that the presence of catechins and epicatechins produced by the endophytic fungus <italic>Diaporthe</italic> sp. had been transformed into dihydroxyflavan derivatives and the endophyte was isolated from the tea plant. Most of the catechins and epicatechin derivatives were extracted from the tea plants but with respect to this investigation, the catechins and epicatechins were present in <italic>A. marmelos</italic> tree and this is the reason the endophyte isolated from this host tree produced the same metabolites [<xref rid="B19-molecules-26-00654" ref-type="bibr">19</xref>].</p><p>The epicatechins and its derivatives have a significant role in treating the cervical cancer by minimizing the cell proliferation in several ways, such as (a) induction of cancerous cell cycle arrest; (b) modulating cancer cell growth; (c) depolymerization of cellular microtubules and inhibition of tubulin assembly; (d) arresting the angiogenesis in cancer cells; and (e) restriction of oncoproteins which has been induced by HPV and oxidative stresses [<xref rid="B10-molecules-26-00654" ref-type="bibr">10</xref>]. The epicatechins family contains the properties in scavenging the free radicals produced during the mitochondrial oxidative stress efficiently [<xref rid="B57-molecules-26-00654" ref-type="bibr">57</xref>,<xref rid="B58-molecules-26-00654" ref-type="bibr">58</xref>]. Several researchers has investigated the cervical cancer therapeutic properties of epicatechins and its derivatives on arresting the cells in G1 phase [<xref rid="B59-molecules-26-00654" ref-type="bibr">59</xref>]; inhibition of signal transduction pathways; activation of redox sensitive transcriptional factors such as AP1 and NF-&#x003ba;B in the cell lines [<xref rid="B60-molecules-26-00654" ref-type="bibr">60</xref>,<xref rid="B61-molecules-26-00654" ref-type="bibr">61</xref>]; inhibition of EGFR signaling which is a beginning kinase in EGF cascades and activation of ERK1/2 and AKT activities [<xref rid="B60-molecules-26-00654" ref-type="bibr">60</xref>]; inhibition of telomerase activity in the progression of cervical cancer lesions [<xref rid="B62-molecules-26-00654" ref-type="bibr">62</xref>,<xref rid="B63-molecules-26-00654" ref-type="bibr">63</xref>,<xref rid="B64-molecules-26-00654" ref-type="bibr">64</xref>]; inhibition of proteasomal activities in HeLa cell line; and suppression of mRNA, ER&#x003b1; and aromatase (protein expression) as a result, the cervical cancer cells enters the apoptotic stage [<xref rid="B65-molecules-26-00654" ref-type="bibr">65</xref>]. The telomerase activity in the endocervical and ectocervical cancer cells in human was inhibited by the therapeutic drug EGCG [<xref rid="B63-molecules-26-00654" ref-type="bibr">63</xref>]. Moreover, in cancer cells, there is a vital role of microtubules majorly in signaling process, proliferation, and metastasis (migration) processes in cervical cancer cells; therefore, the microtubule and tubulin are decisive targets for anti-cancer medicines/drugs. The investigation of Chakraborty et al. [<xref rid="B66-molecules-26-00654" ref-type="bibr">66</xref>] has studied inhibition of HeLa cells&#x02019; proliferation by the implementation of Epicatechins and its derivative and the proliferation of the cancer cells were formed through depolymerizing cellular microtubule and restraining tubulin assembly. Hence, the DoE of current investigation has explicated its maximized anti-cervical cancer activity which was like the epicatechins and its derivatives as stated in the foresaid research. The apoptosis on the HeLa cell lines was effectively implemented by the DoE; the further studies will be explored to determine the inhibition of proliferation in cancer cells and also to analyze the metabolic mechanisms between DoE and cancer cells.</p></sec><sec sec-type="conclusions" id="sec5-molecules-26-00654"><title>5. Conclusions</title><p>In summary, the results obtained in the present study indicated that the metabolite DoE purified from the CPME of <italic>C. australiensis</italic> explored that their potentiality at the minimum concentration. The DoE exhibited its therapeutic properties on cervical cancer cells in minimum dosage; further the carrageenan-induced inflammation on animal models were significantly reduced by the implication of the DoE. This proved that the DoE explicated its therapeutic index towards the treatment of cervical cancer in animal models. Thus, the application of DoE in the cancer therapeutics will reduce the side effects of chemotherapy and aims in curing the cancer. Future research is needed to determine the role of DoE on other tumor cells and the molecular mechanisms against anticancer studies for further development of natural anticancer substances.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors grateful to the National Research Foundation of South Korea (2018R1C1B5086232) by Korean Government (MEST); National Nature Science Foundation of China (32002196); Natural Science Foundation of Guangdong Province (2018A030307023).</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><app-group><app id="app1-molecules-26-00654"><title>Supplementary Materials</title><p>The following are available online, Table S1: Toxicological evaluations of purified compound DoE.</p><supplementary-material content-type="local-data" id="molecules-26-00654-s001"><media xlink:href="molecules-26-00654-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, V.M.M., B.B., and W.-C.L.; Methodology, analysis, and data curation, V.M.M., A.J.P.G.S., and K.P.; Writing&#x02014;original draft preparation, V.M.M. and A.J.P.G.S.; Writing&#x02014;review and editing, V.M.M., K.P., B.B., S.P., U.I., and W.-C.L.; Project administration, Funding acquisition, W.-C.L. and B.B. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes><title>Institutional Review Board Statement</title><p>All animal procedures were performed in accordance with Institutional Animal Ethic Committee guidelines, after getting the approval from the Committee for the Purpose of Control and Supervision of Experiment on Animals at KMCH college of Pharmacy, Coimbatore, Tamil Nadu, India (IAEC No. KMCRET/Ph.D/05/2014-15).</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data presented in this study are available on request from the corresponding author.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></notes><notes><title>Sample Availability</title><p>Samples of the compounds are not available from the authors.</p></notes><ref-list><title>References</title><ref id="B1-molecules-26-00654"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>E.L.</given-names></name><name><surname>Schlecht</surname><given-names>N.F.</given-names></name><name><surname>Saslow</surname><given-names>D.</given-names></name></person-group><article-title>The epidemiology of cervical cancer</article-title><source>Cancer</source><year>2003</year><volume>9</volume><fpage>348</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1097/00130404-200309000-00004</pub-id></element-citation></ref><ref id="B2-molecules-26-00654"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waggoner</surname><given-names>S.E.</given-names></name></person-group><article-title>Cervical cancer</article-title><source>Lancet</source><year>2003</year><volume>361</volume><fpage>2217</fpage><lpage>2225</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(03)13778-6</pub-id><pub-id pub-id-type="pmid">12842378</pub-id></element-citation></ref><ref id="B3-molecules-26-00654"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>T.C.</given-names></name><name><surname>Stoler</surname><given-names>M.H.</given-names></name><name><surname>Behrens</surname><given-names>C.M.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Wright</surname><given-names>T.L.</given-names></name></person-group><article-title>Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test</article-title><source>Gynecol. Oncol.</source><year>2015</year><volume>136</volume><fpage>9</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2014.11.076</pub-id></element-citation></ref><ref id="B4-molecules-26-00654"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Q.</given-names></name><name><surname>Zeng</surname><given-names>Q.</given-names></name><name><surname>Shao</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Song</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name></person-group><article-title>Anti-cervical cancer activity of secondary metabolites of endophytic fungi from <italic>Ginkgo biloba</italic></article-title><source>Cancer Biomark.</source><year>2020</year><volume>28</volume><fpage>371</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.3233/CBM-190462</pub-id><?supplied-pmid 32508319?><pub-id pub-id-type="pmid">32508319</pub-id></element-citation></ref><ref id="B5-molecules-26-00654"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>R.</given-names></name><name><surname>Zou</surname><given-names>W.</given-names></name></person-group><article-title>Endophytes: A rich source of functional metabolites</article-title><source>Natl. Prod. Rep.</source><year>2001</year><volume>18</volume><fpage>448</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1039/b100918o</pub-id><?supplied-pmid 11548053?><pub-id pub-id-type="pmid">11548053</pub-id></element-citation></ref><ref id="B6-molecules-26-00654"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Girmay</surname><given-names>S.</given-names></name><name><surname>Martins da Silva</surname><given-names>V.</given-names></name><name><surname>Perry</surname><given-names>B.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Tan</surname><given-names>G.T.</given-names></name></person-group><article-title>The Role of Endophytic Fungi in the Anticancer Activity of Morinda citrifolia Linn. (Noni)</article-title><source>Evid Based Complement. Alt. Med.</source><year>2015</year><volume>2015</volume><fpage>393960</fpage><pub-id pub-id-type="doi">10.1155/2015/393960</pub-id></element-citation></ref><ref id="B7-molecules-26-00654"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.B.</given-names></name><name><surname>Xiao</surname><given-names>Z.E.</given-names></name><name><surname>Feng</surname><given-names>X.J.</given-names></name><name><surname>Huang</surname><given-names>C.H.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Ju</surname><given-names>J.H.</given-names></name><name><surname>Li</surname><given-names>M.F.</given-names></name><name><surname>Lin</surname><given-names>Y.C.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>She</surname><given-names>Z.G.</given-names></name></person-group><article-title>Cytotoxic naphtho-g-pyrones from the Mangrove endophytic fungus <italic>Aspergillus tubingensis</italic> (GX1-5E)</article-title><source>Helv. Chim. Acta</source><year>2011</year><volume>94</volume><fpage>1732</fpage><lpage>1740</lpage><pub-id pub-id-type="doi">10.1002/hlca.201100050</pub-id></element-citation></ref><ref id="B8-molecules-26-00654"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>X.-M.</given-names></name><name><surname>Meng</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>C.S.</given-names></name><name><surname>Gao</surname><given-names>S.S.</given-names></name><name><surname>Shang</surname><given-names>Z.</given-names></name><name><surname>Proksch</surname><given-names>P.</given-names></name><name><surname>Huang</surname><given-names>C.G.</given-names></name><name><surname>Wang</surname><given-names>B.G.</given-names></name></person-group><article-title>Nigerapyrones A&#x02013;H, &#x003b1;-pyrone derivatives from the marine mangrove-derived endophytic fungus <italic>Aspergillus niger</italic> MA-132</article-title><source>J. Nat. Prod.</source><year>2011</year><volume>74</volume><fpage>1787</fpage><lpage>1791</lpage><pub-id pub-id-type="doi">10.1021/np200381u</pub-id><pub-id pub-id-type="pmid">21774474</pub-id></element-citation></ref><ref id="B9-molecules-26-00654"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majoumouo</surname><given-names>M.S.</given-names></name><name><surname>Tincho</surname><given-names>M.B.</given-names></name><name><surname>Toghueo</surname><given-names>R.M.K.</given-names></name><name><surname>Morris</surname><given-names>T.</given-names></name><name><surname>Hiss</surname><given-names>D.C.</given-names></name><name><surname>Boyom</surname><given-names>F.F.</given-names></name><name><surname>Mandal</surname><given-names>C.</given-names></name></person-group><article-title>Cytotoxicity Potential of Endophytic Fungi Extracts from <italic>Terminalia catappa</italic> against Human Cervical Cancer Cells</article-title><source>J. Toxicol.</source><year>2020</year><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1155/2020/8871152</pub-id></element-citation></ref><ref id="B10-molecules-26-00654"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.Q.</given-names></name><name><surname>Lu</surname><given-names>J.L.</given-names></name><name><surname>Liang</surname><given-names>Y.R.</given-names></name><name><surname>Li</surname><given-names>Q.S.</given-names></name></person-group><article-title>Suppressive Effects of EGCG on Cervical Cancer</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>2334</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23092334</pub-id></element-citation></ref><ref id="B11-molecules-26-00654"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Zeng</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name></person-group><article-title>Cytotoxic metabolites from Botryotinia fuckelianaA-S-3: An endophytic fungus from <italic>Ajuga decumbens</italic></article-title><source>Phytochem. Lett.</source><year>2015</year><volume>13</volume><issue>Suppl. C</issue><fpage>206</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/j.phytol.2015.06.007</pub-id></element-citation></ref><ref id="B12-molecules-26-00654"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bieschke</surname><given-names>J.</given-names></name><name><surname>Russ</surname><given-names>J.</given-names></name><name><surname>Friedrich</surname><given-names>R.P.</given-names></name><name><surname>Ehrnhoefer</surname><given-names>D.E.</given-names></name><name><surname>Wobst</surname><given-names>H.</given-names></name><name><surname>Neugebauer</surname><given-names>K.</given-names></name><name><surname>Wanker</surname><given-names>E.E.</given-names></name></person-group><article-title>EGCG remodels mature &#x003b1;-synuclein and amyloid-&#x003b2; fibrils and reduces cellular toxicity</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2010</year><volume>107</volume><fpage>7710</fpage><lpage>7715</lpage><pub-id pub-id-type="doi">10.1073/pnas.0910723107</pub-id><?supplied-pmid 20385841?><pub-id pub-id-type="pmid">20385841</pub-id></element-citation></ref><ref id="B13-molecules-26-00654"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>F.</given-names></name><name><surname>Abedini</surname><given-names>A.</given-names></name><name><surname>Plesner</surname><given-names>A.</given-names></name><name><surname>Verchere</surname><given-names>C.B.</given-names></name><name><surname>Raleigh</surname><given-names>D.P.</given-names></name></person-group><article-title>The Flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP induced toxicity</article-title><source>Biochemistry</source><year>2010</year><volume>49</volume><fpage>8127</fpage><lpage>8133</lpage><pub-id pub-id-type="doi">10.1021/bi100939a</pub-id><?supplied-pmid 20707388?><pub-id pub-id-type="pmid">20707388</pub-id></element-citation></ref><ref id="B14-molecules-26-00654"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porat</surname><given-names>Y.</given-names></name><name><surname>Abramowitz</surname><given-names>A.</given-names></name><name><surname>Gazit</surname><given-names>E.</given-names></name></person-group><article-title>Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism</article-title><source>Chem. Biol. Drug Des.</source><year>2006</year><volume>67</volume><fpage>27</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1111/j.1747-0285.2005.00318.x</pub-id><?supplied-pmid 16492146?><pub-id pub-id-type="pmid">16492146</pub-id></element-citation></ref><ref id="B15-molecules-26-00654"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>N.</given-names></name><name><surname>Saraiva</surname><given-names>M.J.</given-names></name><name><surname>Almeida</surname><given-names>M.R.</given-names></name></person-group><article-title>Epigallocatechin3-gallate as a potential therapeutic drug for TTR-related amyloidosis: &#x02018;in vivo&#x02019; evidence from FAP mice models</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e29933</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0029933</pub-id><pub-id pub-id-type="pmid">22253829</pub-id></element-citation></ref><ref id="B16-molecules-26-00654"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shay</surname><given-names>J.</given-names></name><name><surname>Elbaz</surname><given-names>H.A.</given-names></name><name><surname>Lee</surname><given-names>I.</given-names></name><name><surname>Zielske</surname><given-names>S.P.</given-names></name><name><surname>Malek</surname><given-names>M.H.</given-names></name><name><surname>H&#x000fc;ttemann</surname><given-names>M.</given-names></name></person-group><article-title>Molecular Mechanisms and Therapeutic Effects of (&#x02212;)-Epicatechin and Other Polyphenols in Cancer, Inflammation, Diabetes, and Neurodegeneration</article-title><source>Oxid. Med. Cell. Longev.</source><year>2015</year><volume>2015</volume><fpage>181260</fpage><pub-id pub-id-type="doi">10.1155/2015/181260</pub-id><pub-id pub-id-type="pmid">26180580</pub-id></element-citation></ref><ref id="B17-molecules-26-00654"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elbaz</surname><given-names>H.A.</given-names></name><name><surname>Lee</surname><given-names>I.</given-names></name><name><surname>Antwih</surname><given-names>D.A.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>H&#x000fc;ttemann</surname><given-names>M.</given-names></name><name><surname>Zielske</surname><given-names>S.P.</given-names></name></person-group><article-title>Epicatechin Stimulates Mitochondrial Activity and Selectively Sensitizes Cancer Cells to Radiation</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e88322</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0088322</pub-id><pub-id pub-id-type="pmid">24516636</pub-id></element-citation></ref><ref id="B18-molecules-26-00654"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagarajan</surname><given-names>S.</given-names></name><name><surname>Nagarajan</surname><given-names>R.</given-names></name><name><surname>Braunhut</surname><given-names>S.J.</given-names></name><name><surname>Bruno</surname><given-names>F.</given-names></name><name><surname>McIntosh</surname><given-names>D.</given-names></name><name><surname>Samuelson</surname><given-names>L.</given-names></name><name><surname>Kumar</surname><given-names>J.</given-names></name></person-group><article-title>Biocatalytically Oligomerized Epicatechin with Potent and Specific Anti-proliferative Activity for Human Breast Cancer Cells</article-title><source>Molecules</source><year>2008</year><volume>13</volume><fpage>2704</fpage><lpage>2716</lpage><pub-id pub-id-type="doi">10.3390/molecules13112704</pub-id><pub-id pub-id-type="pmid">18978700</pub-id></element-citation></ref><ref id="B19-molecules-26-00654"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrasekara</surname><given-names>A.</given-names></name><name><surname>Daugelaite</surname><given-names>J.</given-names></name><name><surname>Shahidi</surname><given-names>F.</given-names></name></person-group><article-title>DNA scission and LDL cholesterol oxidation inhibition and antioxidant activities of <italic>Bael</italic> (<italic>Aegle marmelos)</italic> flower extracts</article-title><source>J. Trad. Complement. Med.</source><year>2018</year><volume>8</volume><fpage>428</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1016/j.jtcme.2017.08.010</pub-id></element-citation></ref><ref id="B20-molecules-26-00654"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondol</surname><given-names>M.A.</given-names></name><name><surname>Farthouse</surname><given-names>J.</given-names></name><name><surname>Islam</surname><given-names>M.T.</given-names></name><name><surname>Sch&#x000fc;ffler</surname><given-names>A.</given-names></name><name><surname>Laatsch</surname><given-names>H.</given-names></name></person-group><article-title>Metabolites from the Endophytic Fungus <italic>Curvularia</italic> sp. M12 Act as Motility Inhibitors against <italic>Phytophthora capsici</italic> Zoospores</article-title><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>347</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b00785</pub-id><pub-id pub-id-type="pmid">28195475</pub-id></element-citation></ref><ref id="B21-molecules-26-00654"><label>21.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Khiralla</surname><given-names>A.</given-names></name></person-group><source>Phytochemical Study, Cytotoxic and Antibacterial Potentialities of Endophytic Fungi from Medicinal Plants from Sudan</source><comment>Other, English. ffNNT: 2015LORR0159ff. fftel-01752032f</comment><publisher-name>Universit&#x000e9; de Lorraine</publisher-name><publisher-loc>Metz, France</publisher-loc><year>2015</year></element-citation></ref><ref id="B22-molecules-26-00654"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mani</surname><given-names>V.M.</given-names></name><name><surname>Soundari</surname><given-names>A.P.G.</given-names></name><name><surname>Karthiyaini</surname><given-names>D.</given-names></name><name><surname>Preethi</surname><given-names>K.</given-names></name></person-group><article-title>Bioprospecting for endophytic fungi and their metabolites from medicinal tree <italic>Aegle marmelos</italic> in Western Ghats, India</article-title><source>Mycobiology</source><year>2015</year><volume>43</volume><fpage>303</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.5941/MYCO.2015.43.3.303</pub-id><?supplied-pmid 26539047?><pub-id pub-id-type="pmid">26539047</pub-id></element-citation></ref><ref id="B23-molecules-26-00654"><label>23.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mani</surname><given-names>V.M.</given-names></name><name><surname>Soundari</surname><given-names>A.P.G.</given-names></name><name><surname>Tamilarasi</surname><given-names>S.</given-names></name></person-group><article-title>Determination of in vitro cytotoxicity and anti-angiogenesis for a bioactive compound from <italic>Aspergillus terrus</italic> FC36AY1 isolated from <italic>Aegle marmelos</italic> around Western Ghats, India</article-title><source>Medicinal Chemistry</source><publisher-name>InTech Open-Book</publisher-name><publisher-loc>London, UK</publisher-loc><year>2018</year><fpage>13</fpage><lpage>28</lpage></element-citation></ref><ref id="B24-molecules-26-00654"><label>24.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>S.M.</given-names></name><name><surname>Bain</surname><given-names>B.J.</given-names></name><name><surname>Bates</surname><given-names>I.</given-names></name></person-group><source>Dacie and Lewis Practical Haematology</source><edition>10th ed.</edition><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2006</year></element-citation></ref><ref id="B25-molecules-26-00654"><label>25.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hoffbrand</surname><given-names>V.</given-names></name><name><surname>Moss</surname><given-names>P.</given-names></name></person-group><source>Essential Haematology: Includes Free Desktop Edition</source><edition>6th ed.</edition><publisher-name>John Wiley and Sons Ltd.</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2011</year></element-citation></ref><ref id="B26-molecules-26-00654"><label>26.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>K.E.</given-names></name><name><surname>Barman</surname><given-names>S.M.</given-names></name></person-group><source>Ganong&#x02019;s Review of Medical Physiology</source><edition>25th ed.</edition><publisher-name>McGraw-Hill Education</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2016</year></element-citation></ref><ref id="B27-molecules-26-00654"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delwatta</surname><given-names>S.L.</given-names></name><name><surname>Gunatilake</surname><given-names>M.</given-names></name><name><surname>Baumans</surname><given-names>V.</given-names></name><name><surname>Seneviratne</surname><given-names>M.D.</given-names></name><name><surname>Dissanayaka</surname><given-names>M.L.B.</given-names></name><name><surname>Batagoda</surname><given-names>S.S.</given-names></name><name><surname>Udagedara</surname><given-names>A.H.</given-names></name><name><surname>Walpola</surname><given-names>P.B.</given-names></name></person-group><article-title>Reference values for selected hematological, biochemical and physiological parameters of Sprague-Dawley rats at the Animal House, Faculty of Medicine, University of Colombo, Sri Lanka</article-title><source>Anim. Model Exp. Med.</source><year>2018</year><volume>1</volume><fpage>250</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1002/ame2.12041</pub-id><?supplied-pmid 30891574?><pub-id pub-id-type="pmid">30891574</pub-id></element-citation></ref><ref id="B28-molecules-26-00654"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussein</surname><given-names>R.R.S.</given-names></name><name><surname>Soliman</surname><given-names>R.H.</given-names></name><name><surname>Abdelhaleem Ali</surname><given-names>A.M.</given-names></name><name><surname>Tawfeik</surname><given-names>M.H.</given-names></name><name><surname>Abdelrahim</surname><given-names>M.E.A.</given-names></name></person-group><article-title>Effect of antiepileptic drugs on liver enzymes</article-title><source>Beni-Suef Univ. J. Basic Appl. Sci.</source><year>2013</year><volume>2</volume><fpage>14</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.bjbas.2013.09.002</pub-id></element-citation></ref><ref id="B29-molecules-26-00654"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khoo</surname><given-names>L.W.</given-names></name><name><surname>Foong Kow</surname><given-names>A.S.</given-names></name><name><surname>Maulidiani</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>M.T.</given-names></name><name><surname>Tan</surname><given-names>C.P.</given-names></name><name><surname>Shaari</surname><given-names>K.</given-names></name><name><surname>Tham</surname><given-names>C.L.</given-names></name><name><surname>Abas</surname><given-names>F.</given-names></name></person-group><article-title>Hematological, Biochemical, Histopathological and 1H-NMR Metabolomics Application in Acute Toxicity Evaluation of <italic>Clinacanthus nutans</italic> Water Leaf Extract</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>2172</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23092172</pub-id></element-citation></ref><ref id="B30-molecules-26-00654"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avwioro</surname><given-names>G.</given-names></name><name><surname>Iyiola</surname><given-names>S.</given-names></name><name><surname>Aghoghovwia</surname><given-names>B.</given-names></name></person-group><article-title>Histological and biochemical markers of the liver of Wistar rats on subchronic oral administration of green tea</article-title><source>N. Am. J. Med. Sci.</source><year>2010</year><volume>2</volume><fpage>376</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.4297/najms.2010.2376</pub-id><?supplied-pmid 22737676?><pub-id pub-id-type="pmid">22737676</pub-id></element-citation></ref><ref id="B31-molecules-26-00654"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>W.Z.</given-names></name><name><surname>Guo</surname><given-names>G.F.</given-names></name><name><surname>Yin</surname><given-names>C.X.</given-names></name><name><surname>Jiang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Qiu</surname><given-names>H.J.</given-names></name><name><surname>Chen</surname><given-names>X.X.</given-names></name><name><surname>Rong</surname><given-names>R.M.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Xia</surname><given-names>L.P.</given-names></name></person-group><article-title>Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer</article-title><source>Colorectal Dis.</source><year>2013</year><volume>15</volume><fpage>443</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1111/codi.12258</pub-id><?supplied-pmid 23621885?><pub-id pub-id-type="pmid">23621885</pub-id></element-citation></ref><ref id="B32-molecules-26-00654"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirchaud</surname><given-names>F.</given-names></name><name><surname>Hermetet</surname><given-names>F.</given-names></name><name><surname>Ablise</surname><given-names>M.</given-names></name><name><surname>Fauconnet</surname><given-names>S.</given-names></name><name><surname>Vuitton</surname><given-names>D.A.</given-names></name><name><surname>Pretet</surname><given-names>J.L.</given-names></name><name><surname>Mougin</surname><given-names>C.</given-names></name></person-group><article-title>Isoliquiriti genin induces caspase-dependent apoptosis via down regulation of hpv16 e6 expression in cervical cancer caski cells</article-title><source>Planta Med.</source><year>2013</year><volume>79</volume><fpage>1628</fpage><lpage>1635</lpage><pub-id pub-id-type="pmid">24214831</pub-id></element-citation></ref><ref id="B33-molecules-26-00654"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasundra</surname><given-names>D.P.</given-names></name><name><surname>Suja</surname><given-names>S.</given-names></name></person-group><article-title>Antioxidant and chemotherapeutic potential of Curcuma amada rhizome extract on benzo(a)pyrene induced cervical carcinoma in Sprague Dawley rats</article-title><source>Asian J. Pharm. Clin. Res.</source><year>2017</year><volume>10</volume><fpage>235</fpage><lpage>242</lpage></element-citation></ref><ref id="B34-molecules-26-00654"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosch</surname><given-names>F.X.</given-names></name><name><surname>Burchell</surname><given-names>A.N.</given-names></name><name><surname>Schiffman</surname><given-names>M.</given-names></name><name><surname>Giuliano</surname><given-names>A.R.</given-names></name><name><surname>De Sanjose</surname><given-names>S.</given-names></name><name><surname>Bruni</surname><given-names>L.</given-names></name><name><surname>Tortolero-Luna</surname><given-names>G.</given-names></name><name><surname>Kjaer</surname><given-names>S.K.</given-names></name><name><surname>Munoz</surname><given-names>N.</given-names></name></person-group><article-title>Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia</article-title><source>Vaccine</source><year>2008</year><volume>26</volume><fpage>K1</fpage><lpage>K16</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2008.05.064</pub-id><pub-id pub-id-type="pmid">18847553</pub-id></element-citation></ref><ref id="B35-molecules-26-00654"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Domenico</surname><given-names>F.</given-names></name><name><surname>Foppoli</surname><given-names>C.</given-names></name><name><surname>Coccia</surname><given-names>R.</given-names></name><name><surname>Perluigi</surname><given-names>M.</given-names></name></person-group><article-title>Antioxidants in cervical cancer: Chemopreventive and chemotherapeutic effects of polyphenols</article-title><source>Biochim. Biophys. Acta</source><year>2012</year><volume>1822</volume><fpage>737</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2011.10.005</pub-id><pub-id pub-id-type="pmid">22019724</pub-id></element-citation></ref><ref id="B36-molecules-26-00654"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darr</surname><given-names>D.</given-names></name><name><surname>Fridovich</surname><given-names>I.</given-names></name></person-group><article-title>Free radicals in cutaneous biology</article-title><source>J. Investig. Dermatol.</source><year>1994</year><volume>102</volume><fpage>671</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1111/1523-1747.ep12374036</pub-id><?supplied-pmid 8176246?><pub-id pub-id-type="pmid">8176246</pub-id></element-citation></ref><ref id="B37-molecules-26-00654"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkel</surname><given-names>T.</given-names></name></person-group><article-title>Oxidant signals and oxidative stress</article-title><source>Curr. Opin. Cell Biol.</source><year>2003</year><volume>15</volume><fpage>247</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/S0955-0674(03)00002-4</pub-id><pub-id pub-id-type="pmid">12648682</pub-id></element-citation></ref><ref id="B38-molecules-26-00654"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishna</surname><given-names>P.B.</given-names></name><name><surname>Krishna</surname><given-names>G.</given-names></name><name><surname>Eppakayala</surname><given-names>L.</given-names></name><name><surname>Prakasham</surname><given-names>R.S.</given-names></name><name><surname>Charya</surname><given-names>M.A.S.</given-names></name></person-group><article-title>Evaluation of the Angiosuppresive Activity of Prodigiosin Using the Chorioallantoic Membrane Assay</article-title><source>Int. J. Chem. Anal. Sci.</source><year>2014</year><volume>5</volume><fpage>31</fpage><lpage>36</lpage></element-citation></ref><ref id="B39-molecules-26-00654"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yildiz</surname><given-names>C.</given-names></name><name><surname>Cetin</surname><given-names>A.</given-names></name><name><surname>Demirci</surname><given-names>F.</given-names></name><name><surname>Polat</surname><given-names>Z.A.</given-names></name><name><surname>Kiyan</surname><given-names>T.</given-names></name><name><surname>Altun</surname><given-names>A.</given-names></name><name><surname>Cetin</surname><given-names>M.</given-names></name><name><surname>Yildiz</surname><given-names>O.K.</given-names></name><name><surname>Goze</surname><given-names>I.</given-names></name></person-group><article-title>Anti angiogenic effects of diltiazem, imatinib and bevacizumab in the CAM assay</article-title><source>Int. J. Sci. Res. Pub.</source><year>2013</year><volume>3</volume><fpage>1</fpage><lpage>8</lpage></element-citation></ref><ref id="B40-molecules-26-00654"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.Q.</given-names></name><name><surname>Miao</surname><given-names>Z.H.</given-names></name></person-group><article-title>Marine-derived angiogenesis inhibitors for cancer therapy</article-title><source>Mar. Drugs</source><year>2013</year><volume>11</volume><fpage>903</fpage><lpage>933</lpage><pub-id pub-id-type="doi">10.3390/md11030903</pub-id><pub-id pub-id-type="pmid">23502698</pub-id></element-citation></ref><ref id="B41-molecules-26-00654"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baliga</surname><given-names>M.S.</given-names></name><name><surname>Meleth</surname><given-names>S.</given-names></name><name><surname>Katiyar</surname><given-names>S.K.</given-names></name></person-group><article-title>Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1cells in vitro and in vivo systems</article-title><source>Clin. Cancer Res.</source><year>2005</year><volume>11</volume><fpage>1918</fpage><lpage>1927</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-1976</pub-id><pub-id pub-id-type="pmid">15756018</pub-id></element-citation></ref><ref id="B42-molecules-26-00654"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fassina</surname><given-names>G.</given-names></name><name><surname>Vene</surname><given-names>R.</given-names></name><name><surname>Morini</surname><given-names>M.</given-names></name><name><surname>Minghelli</surname><given-names>S.</given-names></name><name><surname>Benelli</surname><given-names>R.</given-names></name><name><surname>Noonan</surname><given-names>D.M.</given-names></name><name><surname>Albini</surname><given-names>A.</given-names></name></person-group><article-title>Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate</article-title><source>Clin. Cancer Res.</source><year>2004</year><volume>10</volume><fpage>4865</fpage><lpage>4873</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-03-0672</pub-id><pub-id pub-id-type="pmid">15269163</pub-id></element-citation></ref><ref id="B43-molecules-26-00654"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nihal</surname><given-names>M.</given-names></name><name><surname>Ahmad</surname><given-names>N.</given-names></name><name><surname>Mukhtar</surname><given-names>H.</given-names></name><name><surname>Wood</surname><given-names>G.S.</given-names></name></person-group><article-title>Anti-proliferative and proapoptotic effects of (&#x02212;)-epigallocatechin-3-gallate on human melanoma: Possible implications for the chemoprevention of melanoma</article-title><source>Int. J. Cancer</source><year>2005</year><volume>114</volume><fpage>513</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1002/ijc.20785</pub-id><pub-id pub-id-type="pmid">15609335</pub-id></element-citation></ref><ref id="B44-molecules-26-00654"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukinda</surname><given-names>J.T.</given-names></name><name><surname>Syce</surname><given-names>J.A.</given-names></name></person-group><article-title>Acute and chronic toxicity of the aqueous extract of <italic>Artemisia afra</italic> in rodents</article-title><source>J. Ethnopharmacol.</source><year>2007</year><volume>112</volume><fpage>138</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2007.02.011</pub-id><pub-id pub-id-type="pmid">17367969</pub-id></element-citation></ref><ref id="B45-molecules-26-00654"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>D.</given-names></name><name><surname>Mondal</surname><given-names>S.</given-names></name><name><surname>Ramakrishna</surname><given-names>K.</given-names></name></person-group><article-title>Acute and sub-acute (30-day) toxicity studies of <italic>Aegialitis rotundifolia</italic> Roxb., leaves extract in Wistar rats: Safety assessment of a rare mangrove traditionally utilized as pain antidote</article-title><source>Clin. Phytosci.</source><year>2019</year><volume>5</volume><fpage>13</fpage><pub-id pub-id-type="doi">10.1186/s40816-019-0106-2</pub-id></element-citation></ref><ref id="B46-molecules-26-00654"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balkwill</surname><given-names>F.</given-names></name><name><surname>Mantovani</surname><given-names>A.</given-names></name></person-group><article-title>Inflammation and cancer: Back to Virchow?</article-title><source>Lancet</source><year>2001</year><volume>357</volume><fpage>539</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(00)04046-0</pub-id><pub-id pub-id-type="pmid">11229684</pub-id></element-citation></ref><ref id="B47-molecules-26-00654"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karin</surname><given-names>M.</given-names></name><name><surname>Clevers</surname><given-names>H.</given-names></name></person-group><article-title>Reparative inflammation takes charge of tissue regeneration</article-title><source>Nature</source><year>2016</year><volume>529</volume><fpage>307</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1038/nature17039</pub-id><?supplied-pmid 26791721?><pub-id pub-id-type="pmid">26791721</pub-id></element-citation></ref><ref id="B48-molecules-26-00654"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaked</surname><given-names>H.</given-names></name><name><surname>Hofseth</surname><given-names>L.J.</given-names></name><name><surname>Chumanevich</surname><given-names>A.</given-names></name><name><surname>Chumanevich</surname><given-names>A.A.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Taniguchi</surname><given-names>K.</given-names></name><name><surname>Guma</surname><given-names>M.</given-names></name><name><surname>Shenouda</surname><given-names>S.</given-names></name><name><surname>Clevers</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Chronic epithelial NF-kappa B activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2012</year><volume>109</volume><fpage>14007</fpage><lpage>14012</lpage><pub-id pub-id-type="doi">10.1073/pnas.1211509109</pub-id><?supplied-pmid 22893683?><pub-id pub-id-type="pmid">22893683</pub-id></element-citation></ref><ref id="B49-molecules-26-00654"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>N.</given-names></name><name><surname>Syngle</surname><given-names>A.</given-names></name><name><surname>Krishan</surname><given-names>P.</given-names></name></person-group><article-title>Nitric oxide: Link between inflammation and Endothelial dysfunction in rheumatoid arthritis</article-title><source>Int. J. Angiol.</source><year>2017</year><volume>26</volume><fpage>165</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1055/s-0036-1597577</pub-id><?supplied-pmid 28804234?><pub-id pub-id-type="pmid">28804234</pub-id></element-citation></ref><ref id="B50-molecules-26-00654"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez-Gallego</surname><given-names>J.</given-names></name><name><surname>S&#x000e1;nchez-Campos</surname><given-names>S.</given-names></name><name><surname>Tu&#x000f1;&#x000f3;n</surname><given-names>M.J.</given-names></name></person-group><article-title>Anti-inflammatory properties of dietary flavonoids</article-title><source>Nutr. Hosp.</source><year>2007</year><volume>22</volume><fpage>287</fpage><lpage>293</lpage><?supplied-pmid 17612370?><pub-id pub-id-type="pmid">17612370</pub-id></element-citation></ref><ref id="B51-molecules-26-00654"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouhlali</surname><given-names>E.T.</given-names></name><name><surname>Hmidani</surname><given-names>A.</given-names></name><name><surname>Bourkhis</surname><given-names>B.</given-names></name><name><surname>Khouya</surname><given-names>T.</given-names></name><name><surname>Ramchoun</surname><given-names>M.</given-names></name><name><surname>Filali-Zegzouti</surname><given-names>Y.</given-names></name><name><surname>Alem</surname><given-names>C.</given-names></name></person-group><article-title>Phenolic profile and anti-inflammatory activity of four Moroccan date (<italic>Phoenix dactylifera</italic> L.) seed varieties</article-title><source>Heliyon</source><year>2020</year><volume>6</volume><fpage>e03436</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2020.e03436</pub-id><pub-id pub-id-type="pmid">32149199</pub-id></element-citation></ref><ref id="B52-molecules-26-00654"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todoric</surname><given-names>J.</given-names></name><name><surname>Antonucci</surname><given-names>L.</given-names></name><name><surname>Karin</surname><given-names>M.</given-names></name></person-group><article-title>Review: Targeting Inflammation in Cancer Prevention and Therapy</article-title><source>Cancer Prev. Res.</source><year>2016</year><pub-id pub-id-type="doi">10.1158/1940-6207</pub-id></element-citation></ref><ref id="B53-molecules-26-00654"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Luo</surname><given-names>M.</given-names></name><name><surname>Mu</surname><given-names>F.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Zu</surname><given-names>Y.</given-names></name><name><surname>Yao</surname><given-names>M.</given-names></name></person-group><article-title>Hypocrea lixii, novel endophytic fungi producing anticancer agent cajanol, isolated from pigeon pea (<italic>Cajanus cajan</italic> [L.] Millsp.)</article-title><source>J. Appl. Microbiol.</source><year>2013</year><volume>115</volume><fpage>102</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1111/jam.12195</pub-id><pub-id pub-id-type="pmid">23495919</pub-id></element-citation></ref><ref id="B54-molecules-26-00654"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Q.Y.</given-names></name><name><surname>Jia</surname><given-names>M.</given-names></name><name><surname>Ming</surname><given-names>Q.L.</given-names></name><name><surname>Yue</surname><given-names>W.</given-names></name><name><surname>Rahman</surname><given-names>K.</given-names></name><name><surname>Qin</surname><given-names>L.P.</given-names></name><name><surname>Han</surname><given-names>T.</given-names></name></person-group><article-title>Endophytic fungi with antitumor activities: Their occurrence and anticancer compounds</article-title><source>Crit. Rev. Microbiol.</source><year>2016</year><volume>42</volume><fpage>454</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.3109/1040841X.2014.959892</pub-id><pub-id pub-id-type="pmid">25343583</pub-id></element-citation></ref><ref id="B55-molecules-26-00654"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>Y.R.</given-names></name><name><surname>Ye</surname><given-names>Q.</given-names></name><name><surname>Jin</surname><given-names>J.</given-names></name><name><surname>Liang</surname><given-names>H.</given-names></name><name><surname>Lu</surname><given-names>J.L.</given-names></name><name><surname>Du</surname><given-names>Y.Y.</given-names></name><name><surname>Dong</surname><given-names>J.J.</given-names></name></person-group><article-title>Chemical and instrumental assessment of green tea sensory preference</article-title><source>Int. J. Food Prop.</source><year>2008</year><volume>11</volume><fpage>258</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1080/10942910701299430</pub-id></element-citation></ref><ref id="B56-molecules-26-00654"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibuya</surname><given-names>H.</given-names></name><name><surname>Agusta</surname><given-names>A.</given-names></name><name><surname>Ohashi</surname><given-names>K.</given-names></name><name><surname>Maehara</surname><given-names>S.</given-names></name><name><surname>Simanjuntak</surname><given-names>P.</given-names></name></person-group><article-title>Biooxidation of (+)-catechin and (-)-epicatechin into 3,4-dihydroxyflavan derivatives by the endophytic fungus <italic>Diaporthe</italic> sp. isolated from a tea plant</article-title><source>Chem. Pharm. Bull.</source><year>2005</year><volume>53</volume><fpage>866</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1248/cpb.53.866</pub-id><?supplied-pmid 15997157?><pub-id pub-id-type="pmid">15997157</pub-id></element-citation></ref><ref id="B57-molecules-26-00654"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernatoniene</surname><given-names>J.</given-names></name><name><surname>Kopustinskiene</surname><given-names>D.M.</given-names></name></person-group><article-title>The Role of Catechins in Cellular Responses to Oxidative Stress</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>965</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23040965</pub-id><?supplied-pmid 29677167?><pub-id pub-id-type="pmid">29677167</pub-id></element-citation></ref><ref id="B58-molecules-26-00654"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname><given-names>T.</given-names></name><name><surname>Yokozawa</surname><given-names>T.</given-names></name></person-group><article-title>Direct scavenging of nitric oxide and superoxide by green tea</article-title><source>Food Chem. Toxicol.</source><year>2002</year><volume>40</volume><fpage>1745</fpage><lpage>1750</lpage><pub-id pub-id-type="doi">10.1016/S0278-6915(02)00169-2</pub-id><pub-id pub-id-type="pmid">12419687</pub-id></element-citation></ref><ref id="B59-molecules-26-00654"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>W.S.</given-names></name><name><surname>Huh</surname><given-names>S.W.</given-names></name><name><surname>Bae</surname><given-names>S.M.</given-names></name><name><surname>Lee</surname><given-names>I.P.</given-names></name><name><surname>Lee</surname><given-names>J.M.</given-names></name><name><surname>Namkoong</surname><given-names>S.E.</given-names></name><name><surname>Kim</surname><given-names>C.K.</given-names></name><name><surname>Sin</surname><given-names>J.I.</given-names></name></person-group><article-title>A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression</article-title><source>DNA Cell Biol.</source><year>2003</year><volume>22</volume><fpage>217</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1089/104454903321655846</pub-id><?supplied-pmid 12804120?><pub-id pub-id-type="pmid">12804120</pub-id></element-citation></ref><ref id="B60-molecules-26-00654"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sah</surname><given-names>J.F.</given-names></name><name><surname>Balasubramanian</surname><given-names>S.</given-names></name><name><surname>Eckert</surname><given-names>R.L.</given-names></name><name><surname>Rorke</surname><given-names>E.A.</given-names></name></person-group><article-title>Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>279</volume><fpage>12755</fpage><lpage>12762</lpage><pub-id pub-id-type="doi">10.1074/jbc.M312333200</pub-id><?supplied-pmid 14701854?><pub-id pub-id-type="pmid">14701854</pub-id></element-citation></ref><ref id="B61-molecules-26-00654"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>N.</given-names></name><name><surname>Afaq</surname><given-names>F.</given-names></name><name><surname>Saleem</surname><given-names>M.</given-names></name><name><surname>Ahmad</surname><given-names>N.</given-names></name><name><surname>Mukhtar</surname><given-names>H.</given-names></name></person-group><article-title>Targeting multiple signalling pathways by green tea polyphenol (&#x02212;)-epigallocatechin-3-gallate</article-title><source>Cancer Res.</source><year>2006</year><volume>66</volume><fpage>2500</fpage><lpage>2505</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-3636</pub-id><pub-id pub-id-type="pmid">16510563</pub-id></element-citation></ref><ref id="B62-molecules-26-00654"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>D.J.</given-names></name><name><surname>Burns</surname><given-names>A.C.</given-names></name><name><surname>Kazi</surname><given-names>A.</given-names></name><name><surname>Dou</surname><given-names>Q.P.</given-names></name></person-group><article-title>Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2and LDL receptor</article-title><source>Biochim. Biophys. Acta</source><year>2004</year><volume>1682</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2003.12.006</pub-id><pub-id pub-id-type="pmid">15158750</pub-id></element-citation></ref><ref id="B63-molecules-26-00654"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>M.</given-names></name><name><surname>Noguchi</surname><given-names>M.</given-names></name><name><surname>Nakao</surname><given-names>Y.</given-names></name><name><surname>Pater</surname><given-names>A.</given-names></name><name><surname>Iwasaka</surname><given-names>T.</given-names></name></person-group><article-title>The tea polyphenol, (&#x02212;)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines</article-title><source>Gynecol. Oncol.</source><year>2004</year><volume>92</volume><fpage>197</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2003.09.023</pub-id><pub-id pub-id-type="pmid">14751158</pub-id></element-citation></ref><ref id="B64-molecules-26-00654"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noguchi</surname><given-names>M.</given-names></name><name><surname>Yokoyama</surname><given-names>M.</given-names></name><name><surname>Watanabe</surname><given-names>S.</given-names></name><name><surname>Uchiyama</surname><given-names>M.</given-names></name><name><surname>Nakao</surname><given-names>Y.</given-names></name><name><surname>Hara</surname><given-names>K.</given-names></name><name><surname>Iwasaka</surname><given-names>T.</given-names></name></person-group><article-title>Inhibitory effect of the tea polyphenol, (&#x02212;)-epigallocatechin gallate, on growth of cervical adenocarcinoma cell lines</article-title><source>Cancer Lett.</source><year>2006</year><volume>234</volume><fpage>135</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2005.03.053</pub-id><pub-id pub-id-type="pmid">15907368</pub-id></element-citation></ref><ref id="B65-molecules-26-00654"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Xie</surname><given-names>L.</given-names></name><name><surname>Shi</surname><given-names>X.</given-names></name></person-group><article-title>Cell growth inhibition and gene expression regula-tion by (&#x02212;)-epigallocatechin-3-gallate in human cervical cancer cells</article-title><source>Arch. Pharm. Res.</source><year>2009</year><volume>32</volume><fpage>1309</fpage><lpage>1315</lpage><pub-id pub-id-type="doi">10.1007/s12272-009-1917-3</pub-id><pub-id pub-id-type="pmid">19784588</pub-id></element-citation></ref><ref id="B66-molecules-26-00654"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarty</surname><given-names>S.</given-names></name><name><surname>Ganguli</surname><given-names>A.</given-names></name><name><surname>Das</surname><given-names>A.</given-names></name><name><surname>Nag</surname><given-names>D.</given-names></name><name><surname>Chakrabarti</surname><given-names>G.</given-names></name></person-group><article-title>Epigallocatechin-3-gallate shows anti-proliferative activity in HeLa cells targeting tubulin-microtubule equilibrium</article-title><source>Chem. Biol. Interact.</source><year>2015</year><volume>242</volume><fpage>380</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2015.11.004</pub-id><?supplied-pmid 26554336?><pub-id pub-id-type="pmid">26554336</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-26-00654-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Anti-angiogenic analysis of dimer of epicatechin on egg by HET-CAM test.</p></caption><graphic xlink:href="molecules-26-00654-g001"/></fig><fig id="molecules-26-00654-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Analysis of hematological parameters in treated and control Albino mice. The data presented as mean value &#x000b1; SE (<italic>n</italic> = 3). Group I: Control; Group V: survival (1250 mg/kg); Group IV: lethal (1500 mg/kg). (<bold>A</bold>) Blood hematological analysis (RBC: Red Blood Corpuscles; WBC: White Blood Corpuscles); (<bold>B</bold>) Hb: Hemoglobin; MCHC: Mean Corpuscular Hemoglobin Concentration; (<bold>C</bold>) MCH: Mean Corpuscular Hemoglobin; MCV: Mean Corpuscular Volume; and MPV: Mean Platelet Volume; (<bold>D</bold>) Packed Cell Volume (PCCV) analysis.</p></caption><graphic xlink:href="molecules-26-00654-g002"/></fig><fig id="molecules-26-00654-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Histopathological analysis of acute toxicity studies. Group I: Control; Group V: survival (1250 mg/kg); Group IV: lethal (1500 mg/kg). (<bold>A</bold>) Brain section; (<bold>B</bold>) Heart section; (<bold>C</bold>) Kidney section; (<bold>D</bold>) Liver section; (<bold>E</bold>) Lung section; NN: Normal Neurons; NUR: Neurons Unremarkable; NMM: Normal Myocardium Myocytes; MME: Myocytes Mild Edema; NG: Normal Glomerulus; NH: Normal Hepatocytes; NPT: Normal Portal Tract; HCVC: Hepatocyte Central Vein Congestion; NA: Normal Alveoli; IA: Interconnected Alveoli; PLM: Pigment Laden Macrophages.</p></caption><graphic xlink:href="molecules-26-00654-g003"/></fig><fig id="molecules-26-00654-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Anti-inflammatory analysis of dimer of epicatechin in Wistar rats. The data presented as mean value &#x000b1; SE (<italic>n</italic> = 3). The model was significant with <italic>p</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="molecules-26-00654-g004"/></fig><fig id="molecules-26-00654-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Anti-inflammatory response of dimer of epicatechin (DoE) on Wistar rats.</p></caption><graphic xlink:href="molecules-26-00654-g005"/></fig><fig id="molecules-26-00654-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Determination of hematological, antioxidants, lipid peroxidation (LPO), membrane bound enzymes and tumor markers in control and treated Sprague Dawley (SD) animals. (<bold>A</bold>) Hematological parameters; (<bold>B</bold>) Antioxidants (CAT, SOD, GPx and GSH) in serum and tissues; (<bold>C</bold>) LPO and membrane bound enzymes in serum; (<bold>D</bold>) carcinogenic markers&#x02014;CEA and GGT. All the graphs (<bold>A</bold>&#x02013;<bold>D</bold>) are represented in mean &#x000b1; standard deviation (<italic>n</italic> = 3). Different alphabets (a&#x02013;j) indicate significant differences among treatments (<italic>p</italic> &#x0003c; 0.05)&#x02014;based upon the differences between the experimental groups) according to Tukey&#x02019;s HSD test.</p></caption><graphic xlink:href="molecules-26-00654-g006a"/><graphic xlink:href="molecules-26-00654-g006b"/></fig><fig id="molecules-26-00654-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Histopathology of cervical tissues for control and drug(s) treated SD animals. SD rats from each group was randomly selected. <bold>I</bold>&#x02013;<bold>VII</bold>: Experimental groups; BaP: Benzo (a) pyrene; DoE: Dimer of Epicatechin; CIN1: Cervical intraepithelial neoplasia 1; IED-N: Intraepithelial cells disturbance-neoplasia; SEJ: squamous columnar epithelial junction.</p></caption><graphic xlink:href="molecules-26-00654-g007"/></fig><table-wrap id="molecules-26-00654-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-26-00654-t001_Table 1</object-id><label>Table 1</label><caption><p>Anti-angiogenesis effect of dimer of epicatechin in Hen&#x02019;s Egg Test on Chorio Allantoic Membrane (HET-CAM) test.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Sample</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">For 2 h</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">For 18 h</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No. of Vessels in Untreated CAM</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No. of Vessels in Treated CAM</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition (%)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No. of Vessels in Untreated CAM</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No. of Vessels in Treated CAM</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition (%)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Negative Control (0.9% NaCl)</td><td align="center" valign="middle" rowspan="1" colspan="1">09</td><td align="center" valign="middle" rowspan="1" colspan="1">09</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">09</td><td align="center" valign="middle" rowspan="1" colspan="1">09</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sample-1</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">04</td><td align="center" valign="middle" rowspan="1" colspan="1">66.6</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">01</td><td align="center" valign="middle" rowspan="1" colspan="1">91.67</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sample-1</td><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">03</td><td align="center" valign="middle" rowspan="1" colspan="1">76.92</td><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">01</td><td align="center" valign="middle" rowspan="1" colspan="1">92.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sample-1</td><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">03</td><td align="center" valign="middle" rowspan="1" colspan="1">72.72</td><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">01</td><td align="center" valign="middle" rowspan="1" colspan="1">90.9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Positive Control (1N NaOH)</td><td align="center" valign="middle" rowspan="1" colspan="1">08</td><td align="center" valign="middle" rowspan="1" colspan="1">02</td><td align="center" valign="middle" rowspan="1" colspan="1">75.0</td><td align="center" valign="middle" rowspan="1" colspan="1">08</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acetone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">09</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">08</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.27</td></tr></tbody></table><table-wrap-foot><fn><p>NaCl: Sodium chloride; NaOH: Sodium hydroxide; CAM: Chorio Allantoic Membrane; Sample 1: 200 &#x000b5;L of DoE.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-26-00654-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-26-00654-t002_Table 2</object-id><label>Table 2</label><caption><p>Biochemical parameters of Albino mice in acute toxicity study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">S. No.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biochemical Markers</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Group I</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Group V</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Group IV</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">ALP (IU/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">118.02 &#x000b1; 0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">111.22 &#x000b1; 0.98</td><td align="center" valign="middle" rowspan="1" colspan="1">178.45 &#x000b1; 0.98</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">ALT (IU/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">52.8 &#x000b1; 0.41</td><td align="center" valign="middle" rowspan="1" colspan="1">51.18 &#x000b1; 0.82</td><td align="center" valign="middle" rowspan="1" colspan="1">98.4 &#x000b1; 0.82</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">AST (IU/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">69.16 &#x000b1; 0.49</td><td align="center" valign="middle" rowspan="1" colspan="1">70.24 &#x000b1; 0.61</td><td align="center" valign="middle" rowspan="1" colspan="1">203.39 &#x000b1; 0.52</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">Bilirubin (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.95 &#x000b1; 0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">0.92 &#x000b1; 0.30</td><td align="center" valign="middle" rowspan="1" colspan="1">6.17 &#x000b1; 0.05</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total protein (mg/dL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.4 &#x000b1; 0.36</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.5 &#x000b1; 0.24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.31 &#x000b1; 0.25</td></tr></tbody></table><table-wrap-foot><fn><p>The data presented as mean value &#x000b1; SE (<italic>n</italic> = 3). Group I: Control; Group V: survival (1250 mg/kg); Group IV: lethal (1500 mg/kg). ALP: Alkaline Phosphatase Test; ALT: Alanine Amino Transferase; AST: Aspartate Amino Transferase; IU/L: International Units per Liter.</p></fn></table-wrap-foot></table-wrap></floats-group></article>